fig4
![Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance](https://image.oaes.cc/d7a86691-01c0-46e1-b223-6e1f557847dd/3736.fig.4.jpg)
Figure 4. A schematic presentation showing the effective inhibition drug efflux inhibition by tuned drug administration and release mechanisms, mediated by Cur and DOX co-loaded albumin NPs[55]. Cur: curcumin; DOX: Doxorubicin; NPs: nanoparticles